NCT02437851View on ClinicalTrials.gov

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 21, 2026

Study Completion Date

March 21, 2026

Conditions
Anal Squamous Cell CarcinomaHIV InfectionStage 0 Anal Canal CancerStage I Anal Canal Cancer
Interventions
PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery to remove anal or perianal cancer (SISCCA)

Trial Locations (5)

10011

Laser Surgery Care, New York

10461

Montefiore Medical Center, The Bronx

30303

Grady Health System, Atlanta

94115

University of California, San Francisco, San Francisco

02118

Boston Medical Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

The Emmes Company, LLC

INDUSTRY

collaborator

AIDS and Cancer Specimen Resource

OTHER

collaborator

University of Arkansas

OTHER

lead

AIDS Malignancy Consortium

NETWORK